ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

AACR Changes Its Logo— For The Fifth Time Since 2000

June 11, 2014

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

Upton Wraps Up Reorganization – DCCR Revamped, No Prevention Division

October 12, 1979

Mantel Film Getting Rave Reviews, Not Enough Air Time

July 18, 1986

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006

House Passes 2.8 Percent Increase For NCI

December 11, 2009